Journal of Medicinal Chemistry · 2002 · 29 citations · 9 references
MedicineMedicinal ChemistryPharmacologyDrug DesignDrug DiscoverySynthetic Medicinal ChemistryAnalgesic PharmacologyDrug ReceptorsOpioid AnalgesicsOpioid PharmacologyReceptor PharmacologyAntagonist ActivityCore Scaffold LibrariesOpioid AntagonistsOpioid Receptor AgonistsOpioid Receptor BindingOpioid Receptor Modulators
A library of compounds biased toward opioid receptor antagonist activity was prepared by incorporating N-phenylpropyl-4beta-methyl-5-(3-hydroxyphenyl)morphans as the core scaffold using simultaneous solution phase synthetic methodology. From this library, N-phenylpropyl-4beta-methyl-5-(3-hydroxyphenyl)-7alpha-[3-(1-piperidinyl)propanamido]morphan [(-)-3b] was identified as the first potent and selective kappa opioid receptor antagonist from the 5-phenylmorphan class of opioids.
9
Sandra L. Olmsted, A.E. Takemori, P. S. Portoghese · Journal of Medicinal Chemistry · 1993 · 41 citations · Full text